06Mental, behavioural or neurodevelopmental disorders
Disorders due to substance use or addictive behaviours
Disorders due to substance use
6C4CDisorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
6C4C.2MDMA or related drug dependence, including MDA
6C4C.23
category
MDMA or related drug dependence, including MDA, sustained full remission
Definition After a diagnosis of MDMA or related drug dependence, including MDA, and often following a treatment episode or other intervention (including self-intervention), the person has been abstinent from MDMA or related drugs, including MDA, for 12 months or longer.
Also indexed as
Ecstasy or related drug dependence, sustained full remission MDMA or related drug dependence, including MDA, sustained full remission
Nearby in MDMA or related drug dependence, including MDA
International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).
Release 2026-01.
View this entity in the official WHO ICD-11 browser .
This page reproduces WHO classification content for reference. It is not
medical advice and must not be used to diagnose or treat. For coding
decisions, consult the official release and your national coding guidelines.
About · Data & methodology ·
Privacy · Contact